![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Access to HCV triple therapy with telaprevir or boceprevir in real-life setting in HIV-HCV co-infected patients - ANRS CO13 Hepavih Cohort (France)
|
|
|
Reported by Jules Levin
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, June 30-July 3, 2013, Kuala Lumpur
Speaker: Dominique Salmon
http://pag.ias2013.org/flash.aspx?pid=76
![IAS1.gif](../images/070913/070813-10/IAS1.gif)
![IAS2.gif](../images/070913/070813-10/IAS2.gif)
![IAS3.gif](../images/070913/070813-10/IAS3.gif)
![IAS4.gif](../images/070913/070813-10/IAS4.gif)
![IAS5.gif](../images/070913/070813-10/IAS5.gif)
![IAS6.gif](../images/070913/070813-10/IAS6.gif)
![IAS7.gif](../images/070913/070813-10/IAS7.gif)
![IAS8.gif](../images/070913/070813-10/IAS8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|